What are the responsibilities and job description for the Director, Pricing and Contracting Strategy position at Cogent Biosciences?
Who We Are
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role
The Director, Pricing and Contracting Strategy reports to the VP Value and Access Strategy and is responsible for strategic and operational oversight of pricing and contracting. This individual is accountable for all operations and process-related components of pricing and contracting, including oversight and management of AMP, gross-to-net, state price transparency requirements, contracting implications and operations, contracting strategy, Medicaid best price, and all related components. Finally, this individual will partner closely with the Finance, Commercial Analytics, Account Management, and Sales leadership to determine optimal contracting approach for Cogent. The team led by this individual will manage all contracting processes and SOPs, US Pricing Committee submissions and engagements, and other operational components of contracting. This position will be based in Waltham, Massachusetts.
Responsibilities
$215,000 - 250,000 USD
Target Bonus: 20%
Exact compensation will vary based on skills, experience, and location.
Our Locations
Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building.
Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full-time in this location and we are proud to call this the home of Cogent’s discovery research organization.
Our Offer To You
To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role
The Director, Pricing and Contracting Strategy reports to the VP Value and Access Strategy and is responsible for strategic and operational oversight of pricing and contracting. This individual is accountable for all operations and process-related components of pricing and contracting, including oversight and management of AMP, gross-to-net, state price transparency requirements, contracting implications and operations, contracting strategy, Medicaid best price, and all related components. Finally, this individual will partner closely with the Finance, Commercial Analytics, Account Management, and Sales leadership to determine optimal contracting approach for Cogent. The team led by this individual will manage all contracting processes and SOPs, US Pricing Committee submissions and engagements, and other operational components of contracting. This position will be based in Waltham, Massachusetts.
Responsibilities
- Pricing Strategy
- Partner with Market Access Strategy to develop and execute contracting strategies across segments
- Prepare pricing plans and recommendations in alignment with market dynamics and competitive pressures
- Make pricing recommendations for US launch products and lead pricing research with cross-functional stakeholders
- Pricing & Contracting Operations
- Oversee all aspects of US pricing, including AMP, GTN, and other relevant components
- Evaluate contracting options to balance customer demand and long-term revenue potential
- Develop and monitor KPIs related to contract performance and develop metric-based recommendations for adjustments and considerations
- Oversee the management of all contracts in a compliant manner
- Lead all contracting processes, SOPs, and US Pricing Committee submissions and engagements
- Government Pricing
- Establish processes including government price reporting, state transparency requirements, and other relevant government regulations
- Ensure compliant management
- 10 years of pharmaceutical or biotech experience in market access, pricing, policy, and/or relevant commercial roles
- Demonstrated ability to collaborate cross-functionally and influence decision making, strategy, and execution across partners and functions
- Deep understanding of the access landscape for pharmaceutical benefit products
- Extensive understanding of private and public payers, across all settings of care, including the complexities in each setting
- New product launch and/or start-up experience
- Prior experience in targeted therapies and/or Oncology
- Strong financial management and business acumen
- Experience formulating US pricing policy and strategic contracting framework and governance
$215,000 - 250,000 USD
Target Bonus: 20%
Exact compensation will vary based on skills, experience, and location.
Our Locations
Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building.
Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full-time in this location and we are proud to call this the home of Cogent’s discovery research organization.
Our Offer To You
To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
Salary : $215,000 - $250,000